Literature DB >> 27438020

Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature.

Stergios Zacharoulis1, Andres Morales La Madrid, Pratiti Bandopadhayay, Susan N Chi, Peter Manley, Nicole N J Ullrich, Karen Marcus, Liliana Goumnerova, Robert M Scott, Mark Proctor, Tina Young-Poussaint, Umberto De Girolami, Mark W Kieran.   

Abstract

BACKGROUND: Central neurocytomas (CN) are rare pediatric CNS tumors most often with a benign clinical course. Occasionally, these tumors occur outside the ventricles and are called extraventricular neurocytomas (EVN). We present a retrospective institutional analysis of children with neurocytoma with prolonged follow-up. PROCEDURE: Twelve patients were diagnosed with neurocytoma at our institution between 1993 and 2004.
RESULTS: Six patients were male and the median age at diagnosis was 12 years (1.5 to 16 y). Seven patients had CN and 5 had EVN. Presenting symptoms included headaches (67%), vomiting (50%), nausea (33%), seizures (33%), and mental status changes (25%). Obstructive hydrocephalus was present at diagnosis in 42% of the cases. Younger age and seizures were more common in patients with EVN. Gross total resection (GTR) was achieved in 42% (5/12) of the patients. Patients with GTR received no adjuvant therapy upfront; 1 patient subsequently had recurrence with leptomeningeal disease. Patients with subtotal resection received additional treatment: 1 underwent reoperation (GTR), 2 patients received focal radiation, 2 patients received adjuvant chemotherapy, and 2 patients received craniospinal irradiation followed by chemotherapy. The 20-year overall survival for this cohort was 83% with event free survival of 56%. Overall survival for CNs was 100%, versus 40% for EVN. Event free survival for CNs was 57% and 53% for the EVNs. An MIB-1 fraction >2% was associated with worse prognosis.
CONCLUSIONS: Neurocytomas are rare brain tumors in children usually cured with GTR. Adjuvant focal radiation therapy and/or chemotherapy may improve disease control in cases with subtotal resection, but case-by-case analysis should be done. EVNs might be associated with worse outcome due to a higher proliferative index.

Entities:  

Mesh:

Year:  2016        PMID: 27438020     DOI: 10.1097/MPH.0000000000000627

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014.

Authors:  Shahed Tish; Ghaith Habboub; Jaes Jones; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan; Pablo F Recinos; Varun R Kshettry
Journal:  J Neurooncol       Date:  2019-03-11       Impact factor: 4.130

2.  Atypical central neurocytoma with aggressive features in a child.

Authors:  Scott Sun; Denise M Malicki; Michael L Levy; John Ross Crawford
Journal:  BMJ Case Rep       Date:  2020-06-21

3.  Congenital Extra-Ventricular (Ganglio)Neurocytoma of the Brain Stem: A Case Report.

Authors:  Marta Piras; Evelina Miele; Angela Di Giannatale; Giovanna S Colafati; Francesca Diomedi-Camassei; Maria Vinci; Emmanuel de Billy; Angela Mastronuzzi; Andrea Carai
Journal:  Front Pediatr       Date:  2018-05-11       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.